Cargando…

JAK inhibitors in systemic juvenile idiopathic arthritis

OBJECTIVE: Systemic juvenile idiopathic arthritis (SJIA) is characterized by excessive and inappropriate production of proinflammatory cytokines. Janus kinase inhibitors (JAKi) can block the downstream pathway of many cytokines. The use of JAKi in SJIA or macrophage activation syndrome (MAS) has onl...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Tingyan, Xia, Yu, Luo, Ying, Yang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157237/ https://www.ncbi.nlm.nih.gov/pubmed/37152309 http://dx.doi.org/10.3389/fped.2023.1134312

Ejemplares similares

Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
por: He, Tingyan, et al.
Publicado: (2023)

Isolated Facet Joint Arthritis in Juvenile Idiopathic Arthritis
por: Martone, Giulia, et al.
Publicado: (2021)

Tocilizumab in Systemic Juvenile Idiopathic Arthritis: Response Differs by Disease Duration at Medication Initiation and by Phenotype of Disease
por: Yan, Xin, et al.
Publicado: (2021)

Wilson’s Disease Masquerading as Juvenile Idiopathic Arthritis in an Adolescent
por: Goyal, Rajeev, et al.
Publicado: (2020)

Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis – Two Ends of the Same Spectrum
por: Go, Ellen, et al.
Publicado: (2021)

Systemic juvenile idiopathic arthritis: The Great Ormond Street Hospital experience (2005–2021)
por: Foley, C. M., et al.
Publicado: (2023)

Application of Intra-articular Corticosteroid Injection in Juvenile Idiopathic Arthritis
por: Li, Sha, et al.
Publicado: (2022)

The Importance of Differentiating Oligoarticular Juvenile Idiopathic Arthritis From Lyme Arthritis in Pediatric Patients
por: Jeelani, Wajiha, et al.
Publicado: (2022)

Costs of Hospital‐Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System
por: Kip, Michelle M. A., et al.
Publicado: (2022)

Overlapping Features in Kawasaki Disease-Related Arthritis and Systemic-Onset Juvenile Idiopathic Arthritis: A Nationwide Study in Japan
por: Kanemasa, Hikaru, et al.
Publicado: (2021)

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Identification of novel autoantigens as potential biomarkers in juvenile idiopathic arthritis associated uveitis
por: Arve-Butler, Sabine, et al.
Publicado: (2023)

Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis
por: Golhen, Klervi, et al.
Publicado: (2022)

The Biologic Basis of Clinical Heterogeneity in Juvenile Idiopathic Arthritis
por: Eng, Simon W M, et al.
Publicado: (2014)

Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study
por: Tappeiner, Christoph, et al.
Publicado: (2018)

Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents With Juvenile Idiopathic Arthritis
por: Shoop‐Worrall, Stephanie J. W., et al.
Publicado: (2020)

A Study Protocol for the Management of Children With Juvenile Idiopathic Arthritis Based on ePROs
por: Shen, Biyu, et al.
Publicado: (2022)

Predictive Value of Magnetic Resonance Imaging in Patients With Juvenile Idiopathic Arthritis in Clinical Remission
por: Mazzoni, Marta, et al.
Publicado: (2022)

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Quantifying Temporomandibular Joint Synovitis in Children With Juvenile Idiopathic Arthritis
por: Resnick, Cory M., et al.
Publicado: (2016)

Management of Hepatitis A-induced Macrophage Activation Syndrome With Anakinra in Systemic Juvenile Idiopathic Arthritis: A Case Report
por: AlNouwaiser, Deena N, et al.
Publicado: (2022)

Association of Anxiety With Pain and Disability but Not With Increased Measures of Inflammation in Adolescent Patients With Juvenile Idiopathic Arthritis
por: Hanns, Laura, et al.
Publicado: (2020)

Multicentric Carpo-Tarsal Osteolysis Syndrome Mimicking Juvenile Idiopathic Arthritis: Two Case Reports and Review of the Literature
por: Wu, Junfeng, et al.
Publicado: (2021)

Tumefactive synovial thickening mimicking synovial chondromatosis in the setting of oligoarticular juvenile idiopathic arthritis in a toddler
por: Rousslang, Lee K., et al.
Publicado: (2019)

Validity and Reliability of Four Parent/Patient–Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring
por: van Dijkhuizen, E. H. Pieter, et al.
Publicado: (2022)

Persistent Tenosynovitis, Steroid Dependency and a Hyperpigmented Scaly Macular Rash in a Child With Juvenile Idiopathic Arthritis
por: Papatesta, Eleni Maria, et al.
Publicado: (2020)

Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?
por: Sorokina, Lubov S., et al.
Publicado: (2021)

Prolonged Fever in a Pediatric Patient: A Case of Systemic Juvenile Idiopathic Arthritis (sJIA) Complicated by Macrophage Activation Syndrome (MAS)
por: Cortes, Marianne, et al.
Publicado: (2023)

Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis: A Case Report and Literature Review
por: Jiang, Hongkun, et al.
Publicado: (2020)

Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven‐Year Interim Results
por: Brunner, Hermine I., et al.
Publicado: (2020)

Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study
por: Udaondo, Clara, et al.
Publicado: (2022)

Vitamin D Status Among Children With Juvenile Idiopathic Arthritis: A Multicenter Prospective, Non-randomized, Comparative Study
por: Kondratyeva, Elena I., et al.
Publicado: (2022)

Identification of molecular patterns and diagnostic biomarkers in juvenile idiopathic arthritis based on the gene expression of m(6)A regulators
por: Zhang, Shibo, et al.
Publicado: (2022)

Juvenile idiopathic arthritis with systemic onset with inflammatory bone lesions: two case reports of patients successfully treated with canakinumab and experience gained from literature
por: Alexeeva, Ekaterina I., et al.
Publicado: (2023)

Psychometric Properties of the Pediatric Patient‐Reported Outcomes Measurement Information System Item Banks in a Dutch Clinical Sample of Children With Juvenile Idiopathic Arthritis
por: Luijten, Michiel A. J., et al.
Publicado: (2020)

Distinct Effects of Methotrexate and Etanercept on the B Cell Compartment in Patients With Juvenile Idiopathic Arthritis
por: Glaesener, Stephanie, et al.
Publicado: (2014)

New Insights on Juvenile Psoriatic Arthritis
por: Brunello, Francesco, et al.
Publicado: (2022)

Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
por: Chellapandian, Deepak, et al.
Publicado: (2023)

“Reluctant to Assess Pain”: A Qualitative Study of Health Care Professionals’ Beliefs About the Role of Pain in Juvenile Idiopathic Arthritis
por: Lee, Rebecca Rachael, et al.
Publicado: (2019)

Effect of educational brochure compared with video on disease-related knowledge in patients with juvenile idiopathic arthritis: A randomized controlled trial
por: Sunthornsup, Waraporn, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2vtu4ulnm2k760m1n37b3e4ulc